Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Forty Seven Inc (FTSV)

Forty Seven Inc (FTSV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Forty Seven Inc 1490 O`BRIEN DRIVE SUITE A MENLO PARK CA 94025 USA

www.fortyseveninc.com P: 650-352-4150

Description:

Forty Seven, Inc. is a clinical-stage immuno-oncology company. It focused on developing novel checkpoint therapies to activate macrophages in the fight against cancer. The company's product candidate consists of 5F9, is an IgG4 monoclonal antibody against CD47 which is designed to interfere with recognition of CD47 by the SIRP' receptor on macrophages. Forty Seven, Inc. is based in CA, United States.

Key Statistics

Overview:

Market Capitalization, $K 4,599,379
Shares Outstanding, K 48,156
Annual Sales, $ 15,680 K
Annual Net Income, $ -87,620 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -26,240 K
60-Month Beta 0.40
% of Insider Shareholders 37.40%
% of Institutional Shareholders 71.77%
Float, K 30,146
% Float 62.60%

Growth:

1-Year Return 447.96%
3-Year Return 0.00%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Latest Earnings Date 05/11/20
Earnings Per Share ttm -2.41
EPS Growth vs. Prev Qtr -44.74%
EPS Growth vs. Prev Year 1.79%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

FTSV Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -50.38%
Return-on-Assets % -44.35%
Profit Margin % -558.80%
Debt/Equity 0.00
Price/Sales 293.21
Price/Cash Flow N/A
Price/Book 12.70
Book Value/Share 7.52
Interest Coverage 0.00
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar